Corrigendum: Mucins and Pathogenic Mucin-Like Molecules Are Immunomodulators During Infection and Targets for Diagnostics and Vaccines
- 1Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, Potsdam, Germany
- 2Department of Biology, Chemistry and Pharmacy, Freie Universität Berlin, Berlin, Germany
by Pinzón Martín, S., Seeberger, P. H., and Varón Silva, D. (2019). Front. Chem. 7:710. doi: 10.3389/fchem.2019.00710
In the original article, there was a mistake in Figure 4 as published. The strain for three structures was incorrectly assigned in the figure legend. Structures 3 and 6 were corrected and structures 6–8 required renumbering to fit the text. The correct Figure 4 and legend appear below.
Figure 4. Chemical structure of synthesized glycans from MLMs of Trypanosoma cruzi Colombiana strain (1, 2, 6, 7), Tulahuen strain (3–5), and Y strain (8–13).
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: mucins, mucin-like molecules, O-glycoproteins, cancer, parasites, virus, infection
Citation: Pinzón Martín S, Seeberger PH and Varón Silva D (2019) Corrigendum: Mucins and Pathogenic Mucin-Like Molecules Are Immunomodulators During Infection and Targets for Diagnostics and Vaccines. Front. Chem. 7:846. doi: 10.3389/fchem.2019.00846
Received: 29 October 2019; Accepted: 21 November 2019;
Published: 05 December 2019.
Edited by:Karina Valeria Mariño, Institute of Biology and Experimental Medicine (IBYME), Argentina
Reviewed by:Rosa Muchnik De Lederkremer, University of Buenos Aires, Argentina
Copyright © 2019 Pinzón Martín, Seeberger and Varón Silva. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Daniel Varón Silva, firstname.lastname@example.org